278 related articles for article (PubMed ID: 20453839)
1. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.
Sherborne AL; Hosking FJ; Prasad RB; Kumar R; Koehler R; Vijayakrishnan J; Papaemmanuil E; Bartram CR; Stanulla M; Schrappe M; Gast A; Dobbins SE; Ma Y; Sheridan E; Taylor M; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Moorman AV; Harrison CJ; Tomlinson IP; Richards S; Zimmermann M; Szalai C; Semsei AF; Erdelyi DJ; Krajinovic M; Sinnett D; Healy J; Gonzalez Neira A; Kawamata N; Ogawa S; Koeffler HP; Hemminki K; Greaves M; Houlston RS
Nat Genet; 2010 Jun; 42(6):492-4. PubMed ID: 20453839
[TBL] [Abstract][Full Text] [Related]
2. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
[TBL] [Abstract][Full Text] [Related]
3. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
Zhou X; Liao F; Zhang J; Qin Y; Xu H; Ding Z; Zhang Y; Zhang F
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654170
[TBL] [Abstract][Full Text] [Related]
4. Contributions of IKZF1, DDC, CDKN2A, CEBPE, and LMO1 Gene Polymorphisms to Acute Lymphoblastic Leukemia in a Yemeni Population.
Al-Absi B; Razif MFM; Noor SM; Saif-Ali R; Aqlan M; Salem SD; Ahmed RH; Muniandy S
Genet Test Mol Biomarkers; 2017 Oct; 21(10):592-599. PubMed ID: 28768142
[TBL] [Abstract][Full Text] [Related]
5. A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
Walsh KM; de Smith AJ; Hansen HM; Smirnov IV; Gonseth S; Endicott AA; Xiao J; Rice T; Fu CH; McCoy LS; Lachance DH; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR; Ma X; Metayer C; Wiemels JL
Cancer Res; 2015 Nov; 75(22):4884-94. PubMed ID: 26527286
[TBL] [Abstract][Full Text] [Related]
6. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
[TBL] [Abstract][Full Text] [Related]
7. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype.
Migliorini G; Fiege B; Hosking FJ; Ma Y; Kumar R; Sherborne AL; da Silva Filho MI; Vijayakrishnan J; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson P; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Zimmermann M; Bartram CR; Schrappe M; Greaves M; Stanulla M; Hemminki K; Houlston RS
Blood; 2013 Nov; 122(19):3298-307. PubMed ID: 23996088
[TBL] [Abstract][Full Text] [Related]
8. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.
Vijayakrishnan J; Kumar R; Henrion MY; Moorman AV; Rachakonda PS; Hosen I; da Silva Filho MI; Holroyd A; Dobbins SE; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Heilmann-Heimbach S; Jöckel KH; Greaves M; Harrison CJ; Bartram CR; Schrappe M; Stanulla M; Hemminki K; Houlston RS
Leukemia; 2017 Mar; 31(3):573-579. PubMed ID: 27694927
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
Bertin R; Acquaviva C; Mirebeau D; Guidal-Giroux C; Vilmer E; Cavé H
Genes Chromosomes Cancer; 2003 May; 37(1):44-57. PubMed ID: 12661005
[TBL] [Abstract][Full Text] [Related]
10. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
[TBL] [Abstract][Full Text] [Related]
11. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
Vijayakrishnan J; Sherborne AL; Sawangpanich R; Hongeng S; Houlston RS; Pakakasama S
Leuk Lymphoma; 2010 Oct; 51(10):1870-4. PubMed ID: 20919861
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic variation in IKZF1, ARID5B, CDKN2A, and CEBPE with the risk of acute lymphoblastic leukemia in Tunisian children and their contribution to racial differences in leukemia incidence.
Gharbi H; Ben Hassine I; Soltani I; Safra I; Ouerhani S; Bel Haj Othmen H; Teber M; Farah A; Amouri H; Toumi NH; Abdennebi S; Abbes S; Menif S
Pediatr Hematol Oncol; 2016 Apr; 33(3):157-67. PubMed ID: 27184773
[TBL] [Abstract][Full Text] [Related]
13. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.
Hungate EA; Vora SR; Gamazon ER; Moriyama T; Best T; Hulur I; Lee Y; Evans TJ; Ellinghaus E; Stanulla M; Rudant J; Orsi L; Clavel J; Milne E; Scott RJ; Pui CH; Cox NJ; Loh ML; Yang JJ; Skol AD; Onel K
Nat Commun; 2016 Feb; 7():10635. PubMed ID: 26868379
[TBL] [Abstract][Full Text] [Related]
14. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
Pastorczak A; Górniak P; Sherborne A; Hosking F; Trelińska J; Lejman M; Szczepański T; Borowiec M; Fendler W; Kowalczyk J; Houlston RS; Młynarski W
Leuk Res; 2011 Nov; 35(11):1534-6. PubMed ID: 21889209
[TBL] [Abstract][Full Text] [Related]
15. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
[TBL] [Abstract][Full Text] [Related]
17. p16 gene homozygous deletions in acute lymphoblastic leukemia.
Quesnel B; Preudhomme C; Philippe N; Vanrumbeke M; Dervite I; Lai JL; Bauters F; Wattel E; Fenaux P
Blood; 1995 Feb; 85(3):657-63. PubMed ID: 7833469
[TBL] [Abstract][Full Text] [Related]
18. Using MS-MLPA as an efficient screening tool for detecting 9p21 abnormalities in pediatric acute lymphoblastic leukemia.
Gardiner RB; Morash BA; Riddell C; Wang H; Fernandez CV; Yhap M; Berman JN
Pediatr Blood Cancer; 2012 Jun; 58(6):852-9. PubMed ID: 21796768
[TBL] [Abstract][Full Text] [Related]
19. The Yin and Yang-Like Clinical Implications of the
González-Gil C; Ribera J; Ribera JM; Genescà E
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33435487
[TBL] [Abstract][Full Text] [Related]
20. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
